Cytokine Profile and Immunomodulation in Asymptomatic Human T‐Lymphotropic Virus Type 1‐Infected Blood Donors

Summary: The modulation of the immune response has been used as therapy for clinical disorders associated with human T‐lymphotropic virus type 1 (HTLV‐1) infection. In this study, the cytokine profile was evaluated in 26 asymptomatic HTLV‐1 blood donors. Additionally, both the cell responsible for producing interferon‐&ggr; (IFN‐&ggr;) and the role of exogenous interleukin (IL)‐10 in downregulating IFN‐&ggr; production were studied. Cytokine levels were determined in supernatants of unstimulated lymphocyte cultures by enzyme‐linked immunosorbent assay. The levels of IFN‐&ggr;, tumor necrosis factor‐&agr;, IL‐5, and IL‐10 were higher in supernatants of the lymphocyte cultures taken from HTLV‐1‐infected donors than in those taken from healthy subjects. Although depletion of CD8+ T cells and natural killer cells did not affect IFN‐&ggr; production, depletion of CD4+ T cells significantly decreased IFN‐&ggr; production. Furthermore, at a concentration of 2 ng/ml, IL‐10 had only a minimum effect on IFN‐&ggr; production, although at high concentrations (100 ng/ml), IL‐10 decreased IFN‐&ggr; production by 50% in HTLV‐1‐infected individuals. These data indicate that both T helper 1 and T helper 2 cytokines are elevated in HTLV‐1 infection and that IL‐10 in high concentrations modulates IFN‐&ggr; production in these patients.

[1]  W. Blattner,et al.  SPONTANEOUS LYMPHOCYTE PROLIFERATION IN SYMPTOM-FREE HTLV-I POSITIVE JAMAICANS , 1989, The Lancet.

[2]  K. Eguchi,et al.  Relationship between the clinical efficacy of pentoxifylline treatment and elevation of serum T helper type 2 cytokine levels in patients with human T-lymphotropic virus type I-associated myelopathy. , 1999, Internal medicine.

[3]  J. Banchereau,et al.  Interferon gamma inhibits interleukin 10 production by monocytes , 1993, The Journal of experimental medicine.

[4]  T. Mosmann,et al.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.

[5]  H. Tsuda,et al.  Interleukin‐2 Prevents Programmed Cell Death in Adult T‐Cell Leukemia Cells , 1993, Japanese journal of cancer research : Gann.

[6]  M. Kaplan Human retroviruses and neoplastic disease. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  C. Brodskyn,et al.  Cytotoxicity in patients with different clinical forms of Chagas' disease , 1996, Clinical and experimental immunology.

[8]  W. Blattner,et al.  Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. de Carli,et al.  Human Th1 and Th2 T-cell clones are equally susceptible to infection and immortalization by human T-lymphotropic virus type I. , 1998, The Journal of general virology.

[10]  F. Proietti,et al.  Distribution of human T‐lymphotropic virus type I among blood donors: a nationwide Brazilian study , 1997, Transfusion.

[11]  S. Jacobson,et al.  Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. , 1998, Journal of immunology.

[12]  A. Allison,et al.  Identification of human mononuclear leucocyte populations by esterase staining. , 1977, Clinical and experimental immunology.

[13]  D. Hafler,et al.  Variable immortalizing potential and frequent virus latency in blood-derived T-cell clones infected with human T-cell leukemia virus type I. , 1997, Blood.

[14]  D. Mattson,et al.  Immunological studies in tropical spastic paraparesis , 1990, Annals of neurology.

[15]  R. Badaró,et al.  Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated. , 1989, The Journal of clinical investigation.

[16]  E. Carvalho,et al.  Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis. , 1998, The Journal of infectious diseases.

[17]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[18]  D. Taub,et al.  Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. , 1997, Journal of immunology.

[19]  A. Fauci,et al.  Alteration of T-cell functions by infection with HTLV-I or HTLV-II. , 1984, Science.